Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 3
1988 2
1989 3
1990 3
1991 6
1992 14
1993 19
1994 15
1995 24
1996 26
1997 28
1998 30
1999 36
2000 33
2001 50
2002 29
2003 50
2004 54
2005 60
2006 80
2007 89
2008 85
2009 84
2010 105
2011 97
2012 116
2013 145
2014 145
2015 194
2016 211
2017 225
2018 249
2019 309
2020 324
2021 336
2022 289
2023 255
2024 91

Text availability

Article attribute

Article type

Publication date

Search Results

3,501 results

Results by year

Filters applied: . Clear all
Page 1
Detection of germline variants in Brazilian breast cancer patients using multigene panel testing.
Guindalini RSC, Viana DV, Kitajima JPFW, Rocha VM, López RVM, Zheng Y, Freitas É, Monteiro FPM, Valim A, Schlesinger D, Kok F, Olopade OI, Folgueira MAAK. Guindalini RSC, et al. Sci Rep. 2022 Mar 9;12(1):4190. doi: 10.1038/s41598-022-07383-1. Sci Rep. 2022. PMID: 35264596 Free PMC article.
Genetic diversity of germline variants in breast cancer (BC) predisposition genes is unexplored in miscegenated populations, such those living in Latin America. ...In total, 335 (20.1%) participants carried germline P/LP variants: 167 (10.0%) in BRCA1/2, 122 …
Genetic diversity of germline variants in breast cancer (BC) predisposition genes is unexplored in miscegenated populat …
Breast cancer genes: beyond BRCA1 and BRCA2.
Filippini SE, Vega A. Filippini SE, et al. Front Biosci (Landmark Ed). 2013 Jun 1;18(4):1358-72. doi: 10.2741/4185. Front Biosci (Landmark Ed). 2013. PMID: 23747889 Free article. Review.
Breast cancer (BC) is a heterogeneous disease. The majority of breast cancer cases (about 70 percent) are considered sporadic. ...However, additional research in clinical management of moderate and low-risk variants is needed before full implementation
Breast cancer (BC) is a heterogeneous disease. The majority of breast cancer cases (about 70 percent) are consid
Multi-gene Panel Testing in Breast Cancer Management.
Fountzilas C, Kaklamani VG. Fountzilas C, et al. Cancer Treat Res. 2018;173:121-140. doi: 10.1007/978-3-319-70197-4_8. Cancer Treat Res. 2018. PMID: 29349761 Review.
The clinical validity and utility of multi-gene panel testing is getting better characterized as more data on the significance of moderate-penetrance genes are collected from large, cancer genetic testing studies. In this chapter, we attempt to provide …
The clinical validity and utility of multi-gene panel testing is getting better characterized as more data on the significance …
Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.
Tsaousis GN, Papadopoulou E, Apessos A, Agiannitopoulos K, Pepe G, Kampouri S, Diamantopoulos N, Floros T, Iosifidou R, Katopodi O, Koumarianou A, Markopoulos C, Papazisis K, Venizelos V, Xanthakis I, Xepapadakis G, Banu E, Eniu DT, Negru S, Stanculeanu DL, Ungureanu A, Ozmen V, Tansan S, Tekinel M, Yalcin S, Nasioulas G. Tsaousis GN, et al. BMC Cancer. 2019 Jun 3;19(1):535. doi: 10.1186/s12885-019-5756-4. BMC Cancer. 2019. PMID: 31159747 Free PMC article.
In the past, single-gene analysis of specific high risk genes was used for the determination of the genetic cause of cancer heritability in certain families. ...The majority of referrals included individuals with personal of family history of breast an …
In the past, single-gene analysis of specific high risk genes was used for the determination of the genetic cause of cancer
[Epidemiology and diagnosis of breast cancer].
Budny A, Starosławska E, Budny B, Wójcik R, Hys M, Kozłowski P, Budny W, Brodzik A, Burdan F. Budny A, et al. Pol Merkur Lekarski. 2019 May 27;46(275):195-204. Pol Merkur Lekarski. 2019. PMID: 31152530 Polish.
Breast cancer is the most common cancer in women. Family history of breast cancer, age at menarche, number of pregnancies and births, history of breast biopsies, use of hormone replacement therapy and time from the last menstrual period a
Breast cancer is the most common cancer in women. Family history of breast cancer, age at menarche, numbe
Multigene panel testing for hereditary breast and ovarian cancer in the province of Ontario.
Lerner-Ellis J, Mighton C, Lazaro C, Watkins N, Di Gioacchino V, Wong A, Chang MC, Charames GS. Lerner-Ellis J, et al. J Cancer Res Clin Oncol. 2021 Mar;147(3):871-879. doi: 10.1007/s00432-020-03377-6. Epub 2020 Sep 3. J Cancer Res Clin Oncol. 2021. PMID: 32885271
PURPOSE: The aim of this study was to determine the diagnostic yield of multigene panel testing among patients referred with hereditary breast and ovarian cancer (HBOC). ...The referring physician had the opportunity to choose between several different gen
PURPOSE: The aim of this study was to determine the diagnostic yield of multigene panel testing among patients referred with heredita …
Extended gene panel testing in lobular breast cancer.
van Veen EM, Evans DG, Harkness EF, Byers HJ, Ellingford JM, Woodward ER, Bowers NL, Wallace AJ, Howell SJ, Howell A, Lalloo F, Newman WG, Smith MJ. van Veen EM, et al. Fam Cancer. 2022 Apr;21(2):129-136. doi: 10.1007/s10689-021-00241-5. Epub 2021 Mar 25. Fam Cancer. 2022. PMID: 33763779 Free PMC article.
PURPOSE: Lobular breast cancer (LBC) accounts for ~ 15% of breast cancer. Here, we studied the frequency of pathogenic germline variants (PGVs) in an extended panel of genes in women affected with LBC. METHODS: 302 women with LBC and 1567 …
PURPOSE: Lobular breast cancer (LBC) accounts for ~ 15% of breast cancer. Here, we studied the frequency of path …
Breast Cancer Staging: Updates in the AJCC Cancer Staging Manual, 8th Edition, and Current Challenges for Radiologists, From the AJR Special Series on Cancer Staging.
Teichgraeber DC, Guirguis MS, Whitman GJ. Teichgraeber DC, et al. AJR Am J Roentgenol. 2021 Aug;217(2):278-290. doi: 10.2214/AJR.20.25223. Epub 2021 Feb 17. AJR Am J Roentgenol. 2021. PMID: 33594908 Review.
The standardization of the AJCC TNM staging system for breast cancer allows physicians to evaluate patients with breast cancer using standard language and criteria, assess treatment response, and compare patient outcomes. ...Recent advances in therapy …
The standardization of the AJCC TNM staging system for breast cancer allows physicians to evaluate patients with breast
Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D.
Graffeo R, Rana HQ, Conforti F, Bonanni B, Cardoso MJ, Paluch-Shimon S, Pagani O, Goldhirsch A, Partridge AH, Lambertini M, Garber JE. Graffeo R, et al. Breast. 2022 Oct;65:32-40. doi: 10.1016/j.breast.2022.06.003. Epub 2022 Jun 18. Breast. 2022. PMID: 35772246 Free PMC article. Review.
Breast cancer risk associated with germline likely pathogenic/pathogenic variants (PV) varies by gene, often by penetrance (high >50% or moderate 20-50%), and specific locus. ...For individuals at high risk without any pathogenic or likely pathogenic varia
Breast cancer risk associated with germline likely pathogenic/pathogenic variants (PV) varies by gene, often by penetra
Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women.
Palmer JR, Polley EC, Hu C, John EM, Haiman C, Hart SN, Gaudet M, Pal T, Anton-Culver H, Trentham-Dietz A, Bernstein L, Ambrosone CB, Bandera EV, Bertrand KA, Bethea TN, Gao C, Gnanaolivu RD, Huang H, Lee KY, LeMarchand L, Na J, Sandler DP, Shah PD, Yadav S, Yang W, Weitzel JN, Domchek SM, Goldgar DE, Nathanson KL, Kraft P, Yao S, Couch FJ. Palmer JR, et al. J Natl Cancer Inst. 2020 Dec 14;112(12):1213-1221. doi: 10.1093/jnci/djaa040. J Natl Cancer Inst. 2020. PMID: 32427313 Free PMC article.
BACKGROUND: The risks of breast cancer in African American (AA) women associated with inherited mutations in breast cancer predisposition genes are not well defined. ...We assessed associations between mutations in panel-based genes
BACKGROUND: The risks of breast cancer in African American (AA) women associated with inherited mutations in breast
3,501 results